DREW MILES: Open Payments
NPI 1881158749 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 35 payments from 14 companies in 2025. Trend: 2023 $1,872 · 2024 $614 · 2025 $752
Food & beverage: $675Education: $78
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 10 | $154 |
| Janssen Biotech, Inc. | 3 | $116 |
| Olympus America Inc. | 5 | $97 |
| AVYXA PHARMA, LLC | 3 | $89 |
| Astellas Pharma US Inc | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| TOLMAR, INC. | 2 | $37 |
| Dendreon Pharmaceuticals LLC | 1 | $25 |
| ABBVIE INC. | 1 | $23 |
| Valencia Technologies Corporation | 1 | $22 |
Products named: GEMTESA, iTIND System, ERLEADA, LUTRATE DEPOT, Xtandi, PLUVICTO, ORGOVYX, PROVENGE.
Industry payments across MI — which companies pay providers there.
